The effect of natural honey on the immune system of HIV positive persons

The effect of natural honey on the blood index and biochemical markers of HIV positive persons

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201105246580N1

Enrollment

Registered

2011-09-01

Start date

2011-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV. laberatory evidences of HIV

Interventions

Intervention 1: case group: 1.2 gr/kg/day natural honey for 30 days. Intervention 2: control group: this group does not take honey or placebo.

Treatment - Other

case group: 1.2 gr/kg/day natural honey for 30 days.

control group: this group does not take honey or placebo.

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: HIV positive case. Exclusion criteria: paitient with AIDS; useing antiviral drugs; patient with other infectious diseases during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Wbc. Timepoint: first day and 31th day. Method of measurement: CBC.;CD4. Timepoint: first day and 31th day. Method of measurement: blood sampling.;CD8. Timepoint: first day and 31th day. Method of measurement: blood sampling.;Hemoglobin. Timepoint: first day and 31th day. Method of measurement: CBC.;Platelet. Timepoint: first day and 31th day. Method of measurement: CBC.;Serum protein. Timepoint: first day and 31th day. Method of measurement: blood sampling.;Serum albumin. Timepoint: first day and 31th day. Method of measurement: blood sampling.;Copper level. Timepoint: first day and 31th day. Method of measurement: blood sampling.	—

Measure

Time frame

Wbc. Timepoint: first day and 31th day. Method of measurement: CBC.;CD4. Timepoint: first day and 31th day. Method of measurement: blood sampling.;CD8. Timepoint: first day and 31th day. Method of measurement: blood sampling.;Hemoglobin. Timepoint: first day and 31th day. Method of measurement: CBC.;Platelet. Timepoint: first day and 31th day. Method of measurement: CBC.;Serum protein. Timepoint: first day and 31th day. Method of measurement: blood sampling.;Serum albumin. Timepoint: first day and 31th day. Method of measurement: blood sampling.;Copper level. Timepoint: first day and 31th day. Method of measurement: blood sampling.

—

Secondary

Measure	Time frame
Adverse reactions. Timepoint: during the study. Method of measurement: History taking and examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSepideh Mirzaie

Qom University of Medical Sciences

Mirzaie_se@yahoo.com+98 25 1661 0690

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026